Compare LEG & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LEG | QDEL |
|---|---|---|
| Founded | 1883 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Home Furnishings | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.6B |
| IPO Year | 2018 | 2022 |
| Metric | LEG | QDEL |
|---|---|---|
| Price | $10.20 | $17.76 |
| Analyst Decision | Hold | Hold |
| Analyst Count | 4 | 4 |
| Target Price | $10.50 | ★ $32.75 |
| AVG Volume (30 Days) | ★ 1.6M | 1.3M |
| Earning Date | 05-12-2026 | 01-01-0001 |
| Dividend Yield | ★ 1.96% | N/A |
| EPS Growth | ★ 145.31 | 45.35 |
| EPS | ★ 1.69 | N/A |
| Revenue | ★ $5,203,900,000.00 | $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | $2.85 | $3.86 |
| P/E Ratio | $6.04 | ★ N/A |
| Revenue Growth | ★ 1.37 | N/A |
| 52 Week Low | $6.48 | $17.37 |
| 52 Week High | $13.00 | $37.24 |
| Indicator | LEG | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 32.77 | 24.26 |
| Support Level | $8.59 | N/A |
| Resistance Level | $10.66 | $30.65 |
| Average True Range (ATR) | 0.32 | 1.13 |
| MACD | -0.13 | -0.24 |
| Stochastic Oscillator | 4.09 | 8.09 |
Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.